Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 355, Issue 2, 2015, Pages 191-198

  Bejaoui, Mohamed ^a   Pantazi, Eirini ^a   De Luca, Viviana ^b   Panisello, Arnau ^a   Folch Puy, Emma ^a   Serafin, Anna ^d   Capasso, Clemente ^b   Supuran, S T ^c   Rosselló Catafau, Joan ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Platform of Laboratory Animal Applied Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; CARBONATE DEHYDRATASE INHIBITOR; HIF1A PROTEIN, RAT; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; EX VIVO STUDY; FATTY LIVER; LIVER FUNCTION; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASCULAR RESISTANCE; ANIMAL; COLD; DRUG EFFECTS; ENZYMOLOGY; LIVER; LIVER TRANSPLANTATION; METABOLISM; ORGAN PRESERVATION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; VASCULARIZATION; ZUCKER RAT;

ACETAZOLAMIDE; ANIMALS; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; COLD TEMPERATURE; ENZYME ACTIVATION; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY LIVER; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LIVER TRANSPLANTATION; MALE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN PRESERVATION; PHOSPHORYLATION; RATS, ZUCKER; REPERFUSION INJURY; VASCULAR RESISTANCE;

EID: 84946570822     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.225177     Document Type: Article

References (45)

1. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, and Fago A (2009) Generation of nitric oxide from nitrite by carbonic anhydrase: A possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297: H2068-H2074.
2. An Y, Zhang JZ, Han J, Yang HP, Tie L, Yang XY, Xiaokaiti Y, Pan Y, and Li XJ (2013) Hypoxia-inducible factor-1alpha dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury. Cell Physiol Biochem 32:1151-1166.
3. Anavi S, Harmelin NB, Madar Z, and Tirosh O (2012) Oxidative stress impairs HIF1a activation: A novel mechanism for increased vulnerability of steatotic hepatocytes to hypoxic stress. Free Radic Biol Med 52:1531-1542.
4. Bejaoui M, Pantazi E, Folch-Puy E, Baptista PM, García-Gil A, Adam R, and Roselló- Catafau J (2015) Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One 10(7):e0134499.
5. Bejaoui M, Zaouali MA, Folch-Puy E, Pantazi E, Bardag-Gorce F, Carbonell T, Oliva J, Rimola A, Abdennebi HB, and Roselló-Catafau J (2014) Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. J Pharm Pharmacol 66:62-72.
6. Ben Abdennebi H, Steghens JP, Margonari J, Ramella-Virieux S, Barbieux A, and Boillot O (1998) High-Na1 low-K1 UW cold storage solution reduces reperfusion injuries of the rat liver graft. Transpl Int 11:223-230.
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.r.
8. Caraceni P, Nardo B, Domenicali M, Turi P, Vici M, Simoncini M, De Maria N, Trevisani F, Van Thiel DH, and Derenzini M, et al. (1999) Ischemia-reperfusion injury in rat fatty liver: role of nutritional status. Hepatology 29:1139-1146.
9. Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, and Peralta C (2006) Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79:1881-1894.
10. Chalasani N (2005) Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology 41:690-695.
11. Chirica LC, Elleby B, Jonsson BH, and Lindskog S (1997) The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 244:755-760.
12. Deschenes M (2013) Early allograft dysfunction: causes, recognition, and management. Liver Transpl 19 (Suppl 2):S6-S8.
13. Eipel C, Hübschmann U, Abshagen K, Wagner KF, Menger MD, and Vollmar B (2012) Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers. J Surg Res 173:171-179.
14. Farrell GC, Teoh NC, and McCuskey RS (2008) Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 291:684-692.
15. Fukumori T, Ohkohchi N, Tsukamoto S, and Satomi S (1999) Why is a liver with steatosis susceptible to cold ischemic injury? Transplant Proc 31:548-549.
16. Hakamada K, Sasaki M, Takahashi K, Umehara Y, and Konn M (1997) Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 70: 12-20.
17. Höhne C, Pickerodt PA, Francis RC, Boemke W, and Swenson ER (2007) Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 292:L178-L184.
18. Ichikawa N, Naora K, Hirano H, and Iwamoto K (1998) Quantitation of acetazolamide in rat plasma, brain tissue and cerebrospinal fluid by high-performance liquid chromatography. J Pharm Biomed Anal 17:1415-1421.
19. King LA, Toledo AH, Rivera-Chavez FA, and Toledo-Pereyra LH (2009) Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg 16: 763-770.
20. Kiss B, Dallinger S, Findl O, Rainer G, Eichler HG, and Schmetterer L (1999) Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide. Am J Physiol 276:R1661-R1667.
21. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, and Morishita Y (2002) P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 131:344-349.
22. Liu Q, Izamis ML, Xu H, Berendsen T, Yarmush M, and Uygun K (2013) Strategies to rescue steatotic livers before transplantation in clinical and experimental studies. World J Gastroenterol 19:4638-4650.
23. Luo XY, Takahara T, Hou J, Kawai K, Sugiyama T, Tsukada K, Takemoto M, Takeuchi M, Zhong L, and Li XK (2012) Theaflavin attenuates ischemiareperfusion injury in a mouse fatty liver model. Biochem Biophys Res Commun 417:287-293.
24. Nagrath D, Xu H, Tanimura Y, Zuo R, Berthiaume F, Avila M, Yarmush R, and Yarmush ML (2009) Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng 11:274-283.
25. Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, Yoshimitsu K, Enjoji M, Kotoh K, and Taketomi A, et al. (2005) Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 80:608-612.
26. Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, Tatsuno M, Baek Y, Kitamura N, and Suzuki T, et al. (1997) The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemiareperfusion injury of the rat steatotic liver produced by a choline-methioninedeficient diet. Hepatology 26:670-678.
27. Pantazi E, Zaouali MA, Bejaoui M, Serafin A, Folch-Puy E, Petegnief V, De Vera N, Abdennebi HB, Rimola A, and Rosello-Catafau J (2014) Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int 27;493-503.
28. Pastorekova S, Parkkila S, Pastorek J, and Supuran CT (2004) Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 19:199-229.
29. Pesonen EJ, Linder N, Raivio KO, Sarnesto A, Lapatto R, Höckerstedt K, Mäkisalo H, and Andersson S (1998) Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 114:1009-1015.
30. Ramachandran S, Liaw JM, Jia J, Glasgow SC, Liu W, Csontos K, Upadhya GA, Mohanakumar T, and Chapman WC (2012) Ischemia-reperfusion injury in rat steatotic liver is dependent on NFkB P65 activation. Transpl Immunol 26:201-206.
31. Selzner M and Clavien PA (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105-113.
32. Selzner M, Rüdiger HA, Sindram D, Madden J, and Clavien PA (2000) Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 32: 1280-1288.
33. Supuran CT (2011) Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 3:1165-1180.
34. Supuran CT, Di Fiore A, and De Simone G (2008) Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs 13:383-392.
35. Swenson ER (2014) New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases. Curr Hypertens Rep 16:467.
36. Teramoto K, Bowers JL, Kruskal JB, and Clouse ME (1993) Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 56:1076-1082.
37. Torring MS, Holmgaard K, Hessellund A, Aalkjaer C, and Bek T (2009) The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition. Invest Ophthalmol Vis Sci 50:345-351.
38. Tuettenberg J, Heimann A, and Kempski O (2001) Nitric oxide modulates cerebral blood flow stimulation by acetazolamide in the rat cortex: A laser Doppler scanning study. Neurosci Lett 315:65-68.
39. Xu C, Bailly-Maitre B, and Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115:2656-2664.
40. Xu J, Peng Z, Li R, Dou T, Xu W, Gu G, Liu Y, Kang Z, Tao H, and Zhang JH, et al. (2009) Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats: role of acidosis. Neurosci Lett 451:274-278.
41. Yoshinari D, Takeyoshi I, Kobayashi M, Koyama T, Iijima K, Ohwada S, Matsumoto K, and Morishita Y (2001) Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to University of Wisconsin solution on reperfusion injury in liver transplantation. Transplantation 72:22-27.
42. Zaouali MA, Bardag-Gorce F, Carbonell T, Oliva J, Pantazi E, Bejaoui M, Ben Abdennebi H, Rimola A, and Roselló-Catafau J (2013) Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol 94:352-359.
43. Zaouali MA, Ben Mosbah I, Boncompagni E, Ben Abdennebi H, Mitjavila MT, Bartrons R, Freitas I, Rimola A, and Roselló-Catafau J (2010a) Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol 16:3499-3509.
44. Zaouali MA, Padrissa-Altés S, Ben Mosbah I, Ben Abdennebi H, Boillot O, Rimola A, Saidane-Mosbahi D, and Roselló-Catafau J (2010b) Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol 16: 5693-5700.
45. Zaoualí MA, Reiter RJ, Padrissa-Altés S, Boncompagni E, García JJ, Ben Abnennebi H, Freitas I, García-Gil FA, and Rosello-Catafau J (2011) Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury. J Pineal Res 50:213-221.